Z
Zlate Stojanoski
Researcher at Saints Cyril and Methodius University of Skopje
Publications - 31
Citations - 99
Zlate Stojanoski is an academic researcher from Saints Cyril and Methodius University of Skopje. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 4, co-authored 16 publications receiving 29 citations.
Papers
More filters
Journal ArticleDOI
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey
Livio Pagano,Jon Salmanton-García,Francesco Marchesi,Ola Blennow,Maria Gomes da Silva,Andreas Glenthøj,Jaap van Doesum,Yavuz M. Bilgin,Alberto Lopez-Garcia,F. Itri,R. Nunes Rodrigues,Barbora Weinbergerova,Francesca Farina,Giulia Dragonetti,Caroline Berg Venemyr,Jens Van Praet,Ozren Jakšić,Toni Valković,Iker Falces-Romero,Sonia Martín Pérez,Moraima Jiménez,J. Dávila-Valls,Martin Schonlein,Emanuele Ammatuna,Stef Meers,Mario Delia,Zlate Stojanoski,Anna Nordlander,Tobias Lahmer,László Imre Pinczés,Caterina Buquicchio,Klára Piukovics,Irati Ormazabal-Vélez,Nicola Stefano Fracchiolla,Michail Samarkos,Gustavo-Adolfo Méndez,Jose Angel Hernandez-Rivas,Ildefonso Espigado,Martin Cernan,Verena Petzer,Sylvain Lamure,Roberta Di Blasi,J. Marques de Almeida,Michelina Dargenio,Monika Biernat,Mariarita Sciumè,Cristina de Ramón,N. D. de Jonge,Josip Batinic,Avinash Aujayeb,Monia Marchetti,Guillemette Fouquet,Noemi Fernandez Escalada,Giovanni Zambrotta,M. Sacchi,Anna Guidetti,Fatih Demirken,Lucia Prezioso,Zdenek Racil,Marcio Nucci,Miloš Mladenović,Raphael Liévin,Michaela Hanakova,S. Grafe,Uluhan Sili,Marina Machado,Chiara Cattaneo,Tatjana Adzic-Vukicevic,Luisa Verga,Jorge Labrador,Laman Rahimli,Matteo Bonanni,Francesco Passamonti,Antonio Pagliuca,Paolo Corradini,Martin Hoenigl,Philipp Koehler,Alessandro Busca,Oliver A. Cornely +78 more
TL;DR: While mortality is significantly lower than in the pre-vaccination era, breakthrough COVID-19 in HM is still associated with considerable mortality.
Journal ArticleDOI
Outcome of infection with omicron SARS‐CoV‐2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report
Ola Blennow,Jon Salmanton-García,Piotr Nowak,F. Itri,Jaap van Doesum,Alberto Lopez-Garcia,Francesca Farina,Ozren Jakšić,László Imre Princzés,Yavuz M. Bilgin,Iker Falces-Romero,Moraima Jiménez,Irati Ormazabal-Vélez,Barbora Weinbergerova,Remy Dulery,Zlate Stojanoski,Tobias Lahmer,Noemí Fernández,Jose Angel Hernandez-Rivas,Verena Petzer,N. D. de Jonge,Andreas Glenthøj,Cristina de Ramón,Monika Biernat,Nicola Stefano Fracchiolla,Avinash Aujayeb,Jens Van Praet,Martin Schönlein,Gustavo-Adolfo Méndez,Chiara Cattaneo,Anna Guidetti,Mariarita Sciumè,Emanuele Ammatuna,Raul Cordoba,Nicole Garcia-Pouton,Stefanie Katharina Gräfe,Alba Cabirta,Dominik Wolf,Anna Nordlander,Ramón García-Sanz,Mario Delia,Caroline Berg Venemyr,C Brones,Roberta Di Blasi,Elizabeth de Kort,Stef Meers,Sylvain Lamure,L. Serrano,Maria Merelli,Nicola Coppola,Rui Bergantim,Caroline Besson,Milena Kohn,Jessica Petiti,Carolina Garcia-Vidal,Michelina Dargenio,François Danion,Marina Machado,Rebeca Bailén-Almorox,Martin Hoenigl,Giulia Dragonetti,Louis Yi Ann Chai,Chi Shan Bonnie Kho,Matteo Bonanni,Raphael Liévin,Francesco Marchesi,Oliver A. Cornely,Livio Pagano +67 more
TL;DR: Risk factors, antiviral treatment and outcomes of SARS-CoV-2 omicron variant infection in 593 HM patients included in the EPICOVIDEHA registry are described.
Journal ArticleDOI
B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA)
Maria Stefania Infante,Jon Salmanton-García,Ana Fernández-Cruz,Francesco Marchesi,Ozren Jakšić,Barbora Weinbergerova,Caroline Besson,Rafael F. Duarte,F. Itri,Toni Valković,Tomáš Szotkovski,Alessandro Busca,Anna Guidetti,Andreas Glenthøj,Graham P. Collins,V. Bonuomo,Uluhan Sili,Guldane Cengiz Seval,Marina Machado,Raul Cordoba,Ola Blennow,Ghaith Abu-Zeinah,Sylvain Lamure,Austin G. Kulasekararaj,Iker Falces-Romero,Chiara Cattaneo,Jaap van Doesum,Klára Piukovics,Ali S. Omrani,Gabriele Magliano,Marie-Pierre Ledoux,Cristina de Ramón,Alba Cabirta,Luisa Verga,Alberto Lopez-Garcia,Maria Gomes da Silva,Zlate Stojanoski,Stef Meers,Tobias Lahmer,Sonia Martín Pérez,Julio Dávila-Vals,Jens Van Praet,Michail Samarkos,Yavuz M. Bilgin,Linda Karlsson,Josip Batinic,Anna Nordlander,Martin Schönlein,Martin Hoenigl,Zdenek Racil,Miloš Mladenović,Michaela Hanakova,Giovanni Zambrotta,N. D. de Jonge,Tatjana Adzic-Vukicevic,Raquel Nunes-Rodrigues,Lucia Prezioso,Milan Navrátil,Monia Marchetti,Annarosa Cuccaro,María Calbacho,Antonio Giordano,Oliver A. Cornely,Jose Angel Hernandez-Rivas,Livio Pagano +64 more
TL;DR: Overall mortality rate dropped from 41% during the first semester of 2020 to 25% at the last semester of 2021, but results show increased severity and mortality from COVID-19 in LPDs patients treated with targeted drugs.
Journal ArticleDOI
Association of Killer Cell Immunoglobulin-Like Receptor Genes with the Graft versus Host Disease after Related Haematopoietic Stem Cell Transplantation in Patients with Haematological Malignancies from Republic of Macedonia
TL;DR: The results address the difference between the haematopoietic stem cell transplantation settings with sibling and unrelated donors and suggest that the KIR2DS4*001/002 might be a predisposing factor for severe GVHD in sibling HSCT.
Journal ArticleDOI
Killer Cell Immunoglobulin-Like Receptor Genes Polymorphisms in Macedonian Patients with Haematological Malignancies
TL;DR: Further analysis is needed, involving larger series of patients and targeted at the ligands of the KIRs are needed in order to determine a certain KIR gene and/or genotype as either predisposing, or protecting factor for haematological malignancy in patients from Republic of Macedonia.